Am J Physiol Cell Physiol Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 293: C1404-C1411, 2007. First published August 8, 2007; doi:10.1152/ajpcell.00058.2007
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/4/C1404    most recent
00058.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, Y.
Right arrow Articles by Su, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, Y.
Right arrow Articles by Su, B.

VASCULAR BIOLOGY

MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis

Yong Deng,1,2 Jianhua Yang,2 Marya McCarty,3 and Bing Su1,2

1Department of Immunobiology and Vascular Biology and Transplantation Program, Yale University School of Medicine, New Haven, Connecticut; and Departments of 2Immunology and 3Cancer Biology, University of Texas and M. D. Anderson Cancer Center, Houston, Texas

Submitted 9 February 2007 ; accepted in final form 2 August 2007

Mitogen-activated protein kinase kinase kinase 3 (MEKK3) plays an essential role in embryonic angiogenesis, but its role in tumor growth and angiogenesis is unknown. In this study, we further investigated the role of MEKK3 in embryonic angiogenesis, tumor angiogenesis, and angiogenic factor production. We found that endothelial cells from Mekk3-deficient embryos showed defects in cell proliferation, apoptosis, and interactions with myocardium in the heart. We also found that MEKK3 is required for angiopoietin-1 (Ang1)-induced p38 and ERK5 activation. To study the role of MEKK3 in tumor growth and angiogenesis, we established both wild-type and Mekk3-deficient tumor-like embryonic stem cell lines and transplanted them subcutaneously into nude mice to assess their ability to grow and induce tumor angiogenesis. Mekk3-deficient tumors developed and grew similarly as control Mekk3 wild-type tumors and were also capable of inducing tumor angiogenesis. In addition, we found no differences in the production of VEGF in Mekk3-deficient tumors or embryos. Taken together, our results suggest that MEKK3 plays a critical role in Ang1/Tie2 signaling to control endothelial cell proliferation and survival and is required for endothelial cells to interact with the myocardium during early embryonic development. However, MEKK3 is not essential for tumor growth and angiogenesis.

cardiovascular; mitogen-activated protein kinase; embryonic development



Address for reprint requests and other correspondence: B. Su, Dept. of Immunobiology, Yale Univ. School of Medicine, 10 Amistad St., Rm. 401C, PO Box 208089, New Haven, CT 06520 (e-mail: bing.su{at}yale.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. V. Stevens, D. M. Broka, P. Parker, E. Rogowitz, R. R. Vaillancourt, and T. D. Camenisch
MEKK3 Initiates Transforming Growth Factor {beta}2-Dependent Epithelial-to-Mesenchymal Transition During Endocardial Cushion Morphogenesis
Circ. Res., December 5, 2008; 103(12): 1430 - 1440.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.